Patients Discontinuing Weight-Loss Injections Gain Back Weight Far More Rapidly Compared to People Using Diet and Exercise

Fresh analysis suggests that patients who stop using popular weight-loss injections like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who halt traditional lifestyle programs.

Research printed in a prominent health publication demonstrates that while overweight people often shed about a fifth of their body weight while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month after stopping.

"Individuals using these medications must be informed of the danger of quick weight regain when the therapy is stopped," warns researcher Dr. Susan Jebb.

Such speed of recovery implies a reversion to original mass within about a year and a half.

Weighing Approaches

The research, which reviewed 37 of studies involving thousands of patients, compared the results of the injectable medications with other pills.

Scientists note that individuals who lose weight through diet and exercise usually see a more gradual weight regain—around 0.1 kg a month—after stopping.

The Reason for the Fast Regain

Nutrition scientists suggest the way of the drugs is key to understanding the accelerated regain.

GLP-1 drugs imitate a natural hormone called GLP-1, which moderates hunger.

"Sustained high doses of GLP-1 levels far above than normal might result in the system to produce less of its own natural GLP-1, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a dietetics expert.

"Discontinuation of this hormone supplement results in appetite is unsuppressed, making overeating much more probable."

A Chronic Condition?

Health authorities recommend the injections for individuals with weight-linked medical conditions, alongside prescribed diet and exercise modifications.

Many experts contend that, given the likelihood of weight regain, the treatment might need to be ongoing.

This perspective is supported by pharmaceutical companies, who note that the results "highlight the persistent character of excess weight," akin to managing conditions like high blood pressure.

User Testimonies

People who have discontinued the medication describe a powerful resurgence of cravings.

"It felt as if a trigger that goes on and I was suddenly starving," recalled one woman.

The struggle is worsened if users have not developed lasting lifestyle or habit changes during treatment.

Widespread Interest

Survey data show that a significant number of people in the UK have tried weight-loss jabs in the past year, with interest remaining high.

• Use is higher among females than males.
• The 40s and 50s age group shows the greatest level of interest.
• A large proportion obtain the medications through private prescriptions rather than the NHS.

Ultimately, experts emphasize that while GLP-1 drugs are effective agents for weight loss, they are not a standalone solution and maintained weight loss likely depends on ongoing lifestyle changes.